promid vs clarinet: qual é o seu tratamento de escolha ... · tumor load 64 patients/32 events;...
TRANSCRIPT
![Page 1: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/1.jpg)
PROMID vs CLARINET: Qual é o seu
tratamento de escolha para NET 1ª.
linhaGustavo Colagiovanni Girotto, M.D
CRM-SP 132.895
Investigador Principal do CIP/FUNFARME/FAMERP
Oncologista Clínico do HB/FAMERP e da Santa Casa
de São José do Rio Preto
Membro no CEP da FAMERP & Relator AD HOC na
CONEP/CNS/MS
![Page 2: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/2.jpg)
CONFLITOS DE INTERESSES
1. Participo atualmente de estudos clínicos patrocinados
pelas empresas: Roche/Genentech, BMS, MSD,
Astrazeneca, Merck Serono, Novartis, Janssen,Boston,
TEVA, Celgene, Lilly e Pfizer.
2. Participei nos últimos 12 meses como speaker de eventos
das empresas: Lilly, BMS, Roche, Astra Zeneca, MSD e
Amgen
3. Participo como membro do advisory board das empresas: Recepta Biopharma, Astrazeneca, BMS e Roche
4. Não possuo ações de quaisquer companhias
![Page 3: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/3.jpg)
![Page 4: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/4.jpg)
![Page 5: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/5.jpg)
![Page 6: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/6.jpg)
![Page 7: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/7.jpg)
![Page 8: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/8.jpg)
![Page 9: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/9.jpg)
![Page 10: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/10.jpg)
DADOS DEMOGRÁFICOS
![Page 11: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/11.jpg)
TEMPO ATÉ PROGRESSÃO (ITT)
![Page 12: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/12.jpg)
SOBREVIDA GLOBAL INICIAL
![Page 13: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/13.jpg)
RESULTADOS
PER-PROTOCOL
![Page 14: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/14.jpg)
FATORES PROGNÓSTICOS
![Page 15: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/15.jpg)
QUALIDADE DE VIDA E
RESPOSTA BIOQUÍMICA
![Page 16: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/16.jpg)
![Page 17: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/17.jpg)
SOBREVIDA GLOBAL FINAL
![Page 18: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/18.jpg)
MORTALIDADE FINAL
![Page 19: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/19.jpg)
VOLUME TUMORAL
![Page 20: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/20.jpg)
MORTALIDADE POR VOLUME
TUMORAL HEPÁTICO
![Page 21: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/21.jpg)
MORTALIDADE POR VOLUME
TUMORAL HEPÁTICO <10%
![Page 22: PROMID vs CLARINET: Qual é o seu tratamento de escolha ... · Tumor load 64 patients/32 events; median, 107.6 months Tumor load >10%, 21 patients/16 events; median, 57.5 months 1.00](https://reader035.vdocuments.net/reader035/viewer/2022070905/5f74b3f3ea2ece3be67408d6/html5/thumbnails/22.jpg)